K. Arimori et al., CHARACTERISTIC DIFFERENCE IN GASTROINTESTINAL EXCRETION OF CLARITHROMYCIN AND ROXITHROMYCIN, Biopharmaceutics & drug disposition, 19(7), 1998, pp. 433-438
Excretion characteristics of two new macrolides; clarithromycin and ro
xithromycin, into the intestinal and the gastric lumens was studied by
in situ single-pass perfusion and loop methods in rats. Roxithromycin
maintained higher serum levels than clarithromycin after their intrav
enous administrations at a dose of 5 mg kg(-1) each. Radioactivities o
f clarithromycin and roxithromycin exsorbed into the intestinal lumen
were 8.6 and 18.9% of dose in 2 h, respectively, whereas clarithromyci
n and roxithromycin excreted into the bile were 28.4 and 5.9%, respect
ively. These results suggest that roxithromycin is transported mainly
by exsorption across the intestinal membrane, whereas clarithromycin m
ainly by excretion through the biliary tract. On the other hand, radio
activities of clarithromycin and roxithromycin exsorbed into the gastr
ic lumen were much less then those into the intestinal lumen and were
0.72 and 1.34% of dose in 4 h, respectively. Thus, the exsorption into
the gastric lumen seems to be a minor route for the elimination of bo
th macrolides. Consequently, the transport into the intestinal lumen v
ia the intestinal membrane and/or the bile tract may play a significan
t role in the overall elimination of both macrolides. (C) 1998 John Wi
ley & Sons, Ltd.